ACVR1 | Activin A receptor, type I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACVR1B | Activin A receptor, type IB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
ACVR1C | Activin A receptor, type IC | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ACVR2A | Activin A receptor, type IIA | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Expressed in all |
ACVR2B | Activin A receptor, type IIB | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Mixed |
ACVRL1 | Activin A receptor type II-like 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMHR2 | Anti-Mullerian hormone receptor, type II | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ANKK1 | Ankyrin repeat and kinase domain containing 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ARAF | A-Raf proto-oncogene, serine/threonine kinase | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
BMPR1A | Bone morphogenetic protein receptor, type IA | Cancer-related genes CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
BMPR1B | Bone morphogenetic protein receptor, type IB | CD markers Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
BMPR2 | Bone morphogenetic protein receptor, type II (serine/threonine kinase) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
BRAF | B-Raf proto-oncogene, serine/threonine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ILK | Integrin-linked kinase | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
IRAK2 | Interleukin-1 receptor-associated kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
IRAK3 | Interleukin-1 receptor-associated kinase 3 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
IRAK4 | Interleukin-1 receptor-associated kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
KSR1 | Kinase suppressor of ras 1 | Enzymes Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
KSR2 | Kinase suppressor of ras 2 | Enzymes Plasma proteins Predicted intracellular proteins RAS pathway related proteins
| | | | | Tissue enhanced |
LIMK1 | LIM domain kinase 1 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
LIMK2 | LIM domain kinase 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
LRRK1 | Leucine-rich repeat kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
LRRK2 | Leucine-rich repeat kinase 2 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins RAS pathway related proteins
| | | | | Expressed in all |
RIPK1 | Receptor (TNFRSF)-interacting serine-threonine kinase 1 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes Predicted intracellular proteins
| | | | | Mixed |
RIPK3 | Receptor-interacting serine-threonine kinase 3 | Enzymes Predicted intracellular proteins
| | | | | Mixed |
RIPK4 | Receptor-interacting serine-threonine kinase 4 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
TESK1 | Testis-specific kinase 1 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TESK2 | Testis-specific kinase 2 | Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
TGFBR1 | Transforming growth factor, beta receptor 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
TGFBR2 | Transforming growth factor, beta receptor II (70/80kDa) | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
TNNI3K | TNNI3 interacting kinase | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |